Citation Impact
Citing Papers
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Redox flow batteries: a review
2011 Standout
Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application
2006
DARPP-32 knockout mice exhibit impaired reversal learning in a discriminated operant task
2000 StandoutNobel
The locus coeruleus–noradrenergic system: modulation of behavioral state and state-dependent cognitive processes
2003 Standout
Chronic Mild Stress (CMS) Revisited: Consistency and Behavioural-Neurobiological Concordance in the Effects of CMS
2005 Standout
Rodent data and general hypothesis: antipsychotic action exerted through 5-HT2A receptor antagonism is dependent on increased serotonergic tone
1998 StandoutNobel
Methionine metabolism in mammals
1990 Standout
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
2005 Standout
Dorsal Striatal Size, Shape, and Metabolic Rate in Never-Medicated and Previously Medicated Schizophrenics Performing a Verbal Learning Task
1998
Neuroreceptor imaging in psychiatric disorders
2002
How to diagnose MSA early: the role of magnetic resonance imaging
2005
Bruxism physiology and pathology: an overview for clinicians*
2008 Standout
Synchronization Between Temporal and Parietal Cortex During Multimodal Object Processing in Man
1999 Standout
Mechanisms of action of atypical antipsychotic drugs
1991
Twelve-Month Use of Mental Health Services in the United States
2005 Standout
Schizophrenia
2009 Standout
Neural systems of reinforcement for drug addiction: from actions to habits to compulsion
2005 Standout
Parkinson's disease: clinical features and diagnosis
2008 Standout
Behavioural and biochemical studies of citalopram and WAY 100635 in rat chronic mild stress model
2002
The status of spectral EEG abnormality as a diagnostic test for schizophrenia
2007
Network pharmacology: the next paradigm in drug discovery
2008 Standout
Neuroanatomical and Neurochemical Substrates of Timing
2010 Standout
In vivo imaging of synaptic function in the central nervous system
2009
Age‐related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications
2003 Standout
Comparison of diffusion‐weighted imaging and [123I]IBZM‐SPECT for the differentiation of patients with the Parkinson variant of multiple system atrophy from those with Parkinson's disease
2004
SCAN
1990 Standout
Regionally specific effects of atypical antipsychotic drugs on striatal Fos expression: The nucleus accumbens shell as a locus of antipsychotic action
1992
The Australian multicentre double‐blind comparative study of remoxipride and thioridazine in schizophrenia
1994
Prefrontal cortical dopamine systems and the elaboration of functional corticostriatal circuits: implications for schizophrenia and Parkinson's disease
1993
Diagnosis and Treatment of Hyperprolactinemia: An Endocrine Society Clinical Practice Guideline
2011 Standout
Psychosis as a State of Aberrant Salience: A Framework Linking Biology, Phenomenology, and Pharmacology in Schizophrenia
2002 Standout
Endophenotypes in schizophrenia: A selective review
2009
Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development
2003
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
2011 Standout
The Dopamine Hypothesis of Schizophrenia: Version III--The Final Common Pathway
2009 Standout
Does Fast Dissociation From the Dopamine D2Receptor Explain the Action of Atypical Antipsychotics?: A New Hypothesis
2001
Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement
1999 Standout
Cellular basis of working memory
1995 Standout
Clozapine, single photon emission tomography, and the D2 dopamine receptor blockade hypothesis of schizophrenia
1992
Autoradiographic localization of dopamine D1 and D2 receptors in rat nucleus accumbens: Resistance to differential rearing conditions
1991 Standout
Relationship Between Dopamine D2 Occupancy, Clinical Response, and Side Effects: A Double-Blind PET Study of First-Episode Schizophrenia
2000 Standout
A review of MRI findings in schizophrenia
2001 Standout
From post-traumatic stress disorder to cultural bereavement: Diagnosis of Southeast Asian refugees
1991 Standout
Dopamine D2 receptor occupancy by risperidone: Implications for the timing and magnitude of clinical response
2006
CLASSICAL AND ATYPICAL NEUROLEPTICS, AND BONE MINERAL DENSITY, IN PATIENTS WITH SCHIZOPHRENIA
2002
Transmembrane Signalling Systems in the Brain of Patients with Parkinson's Disease
1993
Sexual dysfunction and antipsychotic treatment
2002
PERSECUTORY DELUSIONS: A REVIEW AND THEORETICAL INTEGRATION
2001
Antipsychotic-Induced Weight Gain: A Comprehensive Research Synthesis
1999 Standout
S-Adenosylmethionine in the treatment of depression
1988
Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials
1999
Pharmacological Management of Schizophrenia in Older Patients
1994
Dopamine D-1 and D-2 receptors in relation to reward and performance: A case for the D-1 receptor as a primary site of therapeutic action of neuroleptic drugs
1990
Vulnerability to Delusions Over Time in Schizophrenia and Affective Disorders
1995
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
2013 Standout
A Meta-analysis of the Efficacy of Second-Generation Antipsychotics
2003
Amisulpride – a selective dopamine antagonist and atypical antipsychotic: results of a meta-analysis of randomized controlled trials
2004
Clinical and Theoretical Implications of 5-HT2 and D2 Receptor Occupancy of Clozapine, Risperidone, and Olanzapine in Schizophrenia
1999
Pharmacology of the Atypical Antipsychotic Remoxipride, a Dopamine D2Receptor Antagonist
2001
Striatal D2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C‐raclopride and positron emission tomography
1992
5 Amidines and Guanidines in Medicinal Chemistry
1993
Electrical Energy Storage for the Grid: A Battery of Choices
2011 StandoutScience
Electrochemical Energy Storage for Green Grid
2011 Standout
EEG Coherence and Musical Thinking
1993
Development of redox flow batteries. A historical bibliography
1989
Abnormal neural oscillations and synchrony in schizophrenia
2010 Standout
Mechanistic Studies on the Cu-Catalyzed Three-Component Reactions of Sulfonyl Azides, 1-Alkynes and Amines, Alcohols, or Water: Dichotomy via a Common Pathway
2008 StandoutNobel
Dopamine D2 Receptor Blockade and Antimigraine Action of Flunarizine
1994
Additions to Metal-Activated Organonitriles
2002 Standout
Striatal D2 Receptor Binding in Sleep Bruxism: A Controlled Study with Iodine-123-Iodobenzamide and Single-photon-emission Computed Tomography
1996
Antipsychotic medication, D2 dopamine receptor blockade and clinical response: a 123I IBZM SPET (single photon emission tomography) study
1993
Model for long QT syndrome type 2 using human iPS cells demonstrates arrhythmogenic characteristics in cell culture
2011 StandoutNobel
A common action of clozapine, haloperidol, and remoxipride on D1- and D2-dopaminergic receptors in the primate cerebral cortex.
1994
Predictive Reward Signal of Dopamine Neurons
1998 Standout
Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care
2011 Standout
The time course of neuroleptic therapy for psychosis: role of learning processes and implications for concepts of psychotic illness
1987
A systematic review of atypical antipsychotic drugs in schizophrenia
2003
Multiple system atrophy: natural history, MRI morphology, and dopamine receptor imaging with 123IBZM-SPECT.
1994
Typical and atypical antipsychotic occupancy of D2 and S2 receptors: An autoradiographic analysis in rat brain
1986
METHYLATION AND MOOD
1984
Increased baseline occupancy of D 2 receptors by dopamine in schizophrenia
2000 Standout
Second consensus statement on the diagnosis of multiple system atrophy
2008 Standout
Use and Misuse of the PSE
1983
Psychotropic Drugs, Cardiac Arrhythmia, and Sudden Death
2003
Guidelines for the diagnosis and management of migraine in clinical practice. Canadian Headache Society.
1997 Standout
Dopamine Receptors: From Structure to Function
1998 Standout
Systematic reviews: CRD's guidance for undertaking reviews in health care
2010 Standout
Persistent discrepancy in international diagnostic practice since 1970
1983
Works of B. Küfferle being referenced
Weak antidepressant response after buspirone augmentation of serotonin reuptake inhibitors in refractory severe depression
1998
Dopamine- and serotonin-receptors in schizophrenia: results of imaging-studies and implications for pharmacotherapy in schizophrenia
1999
In vivo 123 I IBZM SPECT imaging of striatal dopamine-2 receptor occupancy in schizophrenic patients treated with olanzapine in comparison to clozapine and haloperidol
1999
EEG-brain mapping in schizophrenics with predominantly positive and negative symptoms
1990
Striatal dopamine-2 receptor occupancy in psychotic patients treated with risperidone
1996
Treatment of schizophrenic disorders: Algorithms for acute pharmacotherapy
1997
Dopamine D2 Receptor Imaging with SPECT: Studies in Different Neuropsychiatric Disorders
1991
Efficacy, cardiac safety and tolerability of sertindole: a drug surveillance
2000
Sertindole and dopamine D 2 receptor occupancy in comparison to risperidone, clozapine and haloperidol - a 123 I-IBZM SPECT study
1998
A double‐blind multicentre study comparing remoxipride, controlled release formulation, with haloperidol in schizophrenia
1990
Quantitative EEG, SPEM, and Psychometric Studies in Schizophrenics before and during Differential Neuroleptic Therapy
1986
Course Outcome of Delusional Psychoses
1984
Early clinical double-blind study with S-adenosyl-L-methionine: a new potential antidepressant.
1982
Reversal by Physostigmine of Clozapine-Induced Delirium
1977
British Phenomenological and Psychopathological Concepts: A Comparative Review
1982
Computer-Assisted EEG Topography as a Tool in the Evaluation of Actions of Psychoactive Drugs in Patients
1984
Fluperlapine - a Potential Successor to Clozapine
1985
Results of a multicenter AMDP study with fluperlapine in schizophrenic patients.
1984
Preface
1988
Antipsychotic Efficacy of Fluperlapine
1984
Clinical, brain mapping and psychometric studies in negative schizophrenia: comparative trials with amisulpride and fluphenazine
1991
The Genetics of Delusional Psychoses
1983